SecProbe.io

Filing text and metadata
Intelligence Terminal Search Probe Scores Topics IPO Watchlist Monthly Activity About API

SEC Comment Letter for CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) (CIK 0001187953) (CELZ) — Aug 21, 2012

CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) (CIK 0001187953)
Date: Aug. 21, 2012 · CIK: 0001187953 · Accession: 0000000000-12-045393

AI Filing Summary & Sentiment

Date
August 21, 2012
Author
/s/ Jeffrey Gordon
Form
UPLOAD
Company
CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) (CIK 0001187953)

Letter

August 21, 2012 Via E -mail Mr. Steven L. White President Jolley Marketing, Inc. 664 South Alvey Dr. Mapleton, UT 84664

RE: Jolley Marketing, Inc. Item 4.01 Form 8 -K Filed August 13, 2012 File No. 0 -53500

Dear Mr. White :

We have completed our review of your filings. We remind you that our comments or changes to disclosure in response to our comments do not foreclose the Commission from taking any action with respect to the company or the filing s and the company may not assert staff comments as a defense in any proceeding initiated by the Commission or any person under the federal securities laws of the United States. We urge all persons who are responsible for the accuracy and adequacy of the disclosure in the filing s to be certain that the filing s include the information the Securities Exchange Act of 1934 and a ll applicable rules require.

Sincerely,
/s/ Jeffrey Gordon

Show Raw Text
August 21, 2012

Via E -mail
Mr. Steven L. White
President
Jolley Marketing, Inc.
664 South Alvey Dr.
Mapleton, UT  84664

RE: Jolley Marketing, Inc.
Item 4.01 Form 8 -K
Filed August 13, 2012
File No. 0 -53500

Dear Mr. White :

We have completed our review of your filings.  We remind you that our comments or
changes to disclosure in response to our comments do not foreclose the Commission from taking
any action with respect to the company or the filing s and the company may not assert staff
comments as a defense in any proceeding initiated by the Commission or any person under the
federal securities laws of the United States.  We urge all persons who are responsible for the
accuracy and adequacy of the disclosure in the filing s to be certain that the filing s include the
information the Securities Exchange Act of 1934 and a ll applicable rules require.

Sincerely,

 /s/ Jeffrey Gordon

 Jeffrey Gordon
Staff Accountant